Literature DB >> 16103030

Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study.

Linn Getz1, Johann A Sigurdsson, Irene Hetlevik, Anna Luise Kirkengen, Solfrid Romundstad, Jostein Holmen.   

Abstract

OBJECTIVE: To estimate the high risk group for cardiovascular disease in a well defined Norwegian population according to European guidelines and the systematic coronary risk evaluation system.
DESIGN: Modelling study.
SETTING: Nord-Tröndelag health study 1995-7 (HUNT 2), Norway. PARTICIPANTS: 5548 participants of the Nord-Tröndelag health study 1995-7, aged 40, 50, 55, 60, and 65. MAIN OUTCOME MEASURES: Distribution of risk categories for cardiovascular disease, with emphasis on the high risk group. MAIN
RESULTS: At age 40, 22.5% (95% confidence interval 19.3% to 25.7%) of women and 85.9% (83.2% to 88.6%) of men were at high risk of cardiovascular disease. Corresponding numbers at age 50 were 39.5% (35.9% to 43.1%) and 88.7% (86.3% to 91.0%) and at age 65 were 84.0% (80.6% to 87.4%) and 91.6% (88.6% to 94.1%). At age 40, one out of 10 women and no men would be classified at low risk for cardiovascular disease.
CONCLUSION: Implementation of the 2003 European guidelines on prevention of cardiovascular disease in clinical practice would classify most adult Norwegians at high risk for fatal cardiovascular disease.

Entities:  

Mesh:

Year:  2005        PMID: 16103030      PMCID: PMC1200589          DOI: 10.1136/bmj.38555.648623.8F

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  19 in total

1.  Ethics and public health: forging a strong relationship.

Authors:  Daniel Callahan; Bruce Jennings
Journal:  Am J Public Health       Date:  2002-02       Impact factor: 9.308

Review 2.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

3.  Primary care: is there enough time for prevention?

Authors:  Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

4.  A matter of heart: the general practitioner consultation in an evidence-based world.

Authors:  Linn Getz; Peter M Nilsson; Irene Hetlevik
Journal:  Scand J Prim Health Care       Date:  2003-03       Impact factor: 2.581

5.  Screening for cardiovascular risk: public health imperative or matter for individual informed choice?

Authors:  Theresa M Marteau; Ann Louise Kinmonth
Journal:  BMJ       Date:  2002-07-13

6.  Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997.

Authors:  K Midthjell; O Krüger; J Holmen; A Tverdal; T Claudi; A Bjørndal; P Magnus
Journal:  Diabetes Care       Date:  1999-11       Impact factor: 19.112

7.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

8.  Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study.

Authors:  Tom Marshall; Andrew Rouse
Journal:  BMJ       Date:  2002-07-27

9.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

10.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Authors:  Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

View more
  19 in total

1.  Assessment of cardiovascular risk in primary health care.

Authors:  Päivi Korhonen; Risto Vesalainen; Pertti Aarnio; Hannu Kautiainen; Salme Järvenpää; Ilkka Kantola
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

Review 2.  Should we lower cholesterol as much as possible?

Authors:  Uffe Ravnskov; Paul J Rosch; Morley C Sutter; Mark C Houston
Journal:  BMJ       Date:  2006-06-03

3.  Cardiovascular risk tables.

Authors:  Thierry Christiaens
Journal:  BMJ       Date:  2008-06-23

4.  Adherence to preventive statin therapy according to socioeconomic position.

Authors:  Helle Wallach-Kildemoes; Morten Andersen; Finn Diderichsen; Theis Lange
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

5.  Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK).

Authors:  Mette Brekke; Magne Rekdal; Jørund Straand
Journal:  Scand J Prim Health Care       Date:  2007-06       Impact factor: 2.581

6.  Self-rated cardiovascular risk and 15-year cardiovascular mortality.

Authors:  Robert Gramling; William Klein; Mary Roberts; Molly E Waring; David Gramling; Charles B Eaton
Journal:  Ann Fam Med       Date:  2008 Jul-Aug       Impact factor: 5.166

7.  Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors.

Authors:  H S Haugnes; N Aass; S D Fosså; O Dahl; O Klepp; E A Wist; T Wilsgaard; R M Bremnes
Journal:  J Cancer Surviv       Date:  2008-05-29       Impact factor: 4.442

8.  Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.

Authors:  Halfdan Petursson; Johann A Sigurdsson; Calle Bengtsson; Tom I L Nilsen; Linn Getz
Journal:  J Eval Clin Pract       Date:  2011-09-25       Impact factor: 2.431

9.  Current European guidelines for management of arterial hypertension: are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 population.

Authors:  Halfdan Petursson; Linn Getz; Johann A Sigurdsson; Irene Hetlevik
Journal:  BMC Fam Pract       Date:  2009-10-30       Impact factor: 2.497

10.  Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.

Authors:  Helle Wallach-Kildemoes; Finn Diderichsen; Allan Krasnik; Theis Lange; Morten Andersen
Journal:  BMC Public Health       Date:  2012-08-04       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.